Future cardiology最新文献_第2页

Evaluating the dual-energy Thermocool SmartTouch SF catheter in the treatment of atrial fibrillation. 双能Thermocool SmartTouch SF导管治疗心房颤动的疗效评价。

IF 1.1

Future cardiology Pub Date : 2026-09-01 Epub Date: 2026-08-27 DOI: 10.1080/14796678.2026.2724775

Miloud Cherbi, Jean-Benoît le Polain de Waroux, Maarten A J De Smet, El Mehdi Channan, Broes Martens, Jesús Diz-Díaz, Nicolas Blankoff, Rene Tavernier, Mattias Duytschaever, Sebastien Knecht

{"title":"Evaluating the dual-energy Thermocool SmartTouch SF catheter in the treatment of atrial fibrillation.","authors":"Miloud Cherbi, Jean-Benoît le Polain de Waroux, Maarten A J De Smet, El Mehdi Channan, Broes Martens, Jesús Diz-Díaz, Nicolas Blankoff, Rene Tavernier, Mattias Duytschaever, Sebastien Knecht","doi":"10.1080/14796678.2026.2724775","DOIUrl":"10.1080/14796678.2026.2724775","url":null,"abstract":"Background: The Dual-Energy THERMOCOOL SMARTTOUCH® SurroundFlow (DE STSF) catheter combines radiofrequency (RF) and pulsed field ablation (PFA) within a single contact force-sensing, irrigated-tip focal platform, fully integrated with the CARTO® 3 three-dimensional mapping system.Methods: We reviewed available preclinical and clinical evidence on the DE STSF catheter, including the first-in-human SmartfIRE trial and supporting preclinical studies.Results: Preclinical data established comparable lesion durability between focal PF and RF ablation, superior scar maturity with PFA, a validated PF ablation index based on contact force and pulse count, and synergistic lesion depth enhancement with sequential RF+PFA delivery. In the SmartfIRE study (n = 149, 9 European centers), acute procedural success was 100%, with no atrio-esophageal fistula, phrenic nerve palsy, or stroke reported. Freedom from atrial arrhythmia recurrence at 12 months reached 71.5% overall and 86.9% in patients treated with high adherence to the dual-index guided workflow.Conclusion: The DE STSF catheter offers a clinically flexible, index-guided dual-energy approach with a favorable safety profile and promising mid-term efficacy, although this evidence derives from a single-arm study lacking randomized or head-to-head comparative data and should be considered hypothesis-generating. Evidence remains limited to paroxysmal AF, and dedicated comparative studies in persistent AF and ventricular arrhythmias are warranted.","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"901-909"},"PeriodicalIF":1.1,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13613893/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148827344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Transcatheter pulmonary flow restriction in congenital heart disease: evolving concepts and future perspectives. 先天性心脏病经导管肺血流限制：不断发展的概念和未来的观点。

IF 1.1

Future cardiology Pub Date : 2026-09-01 Epub Date: 2026-08-28 DOI: 10.1080/14796678.2026.2724781

Raymond N Haddad

{"title":"Transcatheter pulmonary flow restriction in congenital heart disease: evolving concepts and future perspectives.","authors":"Raymond N Haddad","doi":"10.1080/14796678.2026.2724781","DOIUrl":"10.1080/14796678.2026.2724781","url":null,"abstract":"Pulmonary artery banding (PAB) remains an important palliative strategy in congenital heart disease (CHD), particularly for temporary modulation of pulmonary blood flow and pressure during staged management. Over the past two decades, catheter-based pulmonary flow restrictors (PFRs) have emerged as less invasive alternatives to surgery, expanding treatment options for fragile infants and selected older patients. This review traces the evolution of transcatheter PFR, from early experimental concepts to off-label use of manually fenestrated Medtronic microvascular plugs (MVPs). It examines device mechanics, fenestration geometry and technique, implantation strategies, pulmonary vascular interaction, complications, antithrombotic management, retrieval, and long-term limitations. Key challenges include non-standardized fenestration, device-vessel mismatch, progressive loss of restriction with growth, anatomy-dependent performance, and increasingly time-dependent retrieval difficulty. The principal strength of the MVP-based approach is its intraprocedural adaptability, allowing fenestration to be tailored to individual anatomy, hemodynamics, and therapeutic goals. Given the dynamic and heterogeneous physiology of CHD, future dedicated platforms should preserve this adaptability rather than impose a fixed design. Technical refinement should therefore remain embedded within a patient-centered strategy that allows ongoing adjustment. Multicenter registries and purpose-built platforms may help define the future of controlled and durable transcatheter pulmonary flow modulation.","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"929-938"},"PeriodicalIF":1.1,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13613919/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148850281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Interventional treatment options for elderly patients with mitral regurgitation. 老年二尖瓣反流的介入治疗选择。

IF 1.1

Future cardiology Pub Date : 2026-09-01 Epub Date: 2026-08-17 DOI: 10.1080/14796678.2026.2718644

Dominik Felbel, Wolfgang Rottbauer, Mirjam Keßler

{"title":"Interventional treatment options for elderly patients with mitral regurgitation.","authors":"Dominik Felbel, Wolfgang Rottbauer, Mirjam Keßler","doi":"10.1080/14796678.2026.2718644","DOIUrl":"10.1080/14796678.2026.2718644","url":null,"abstract":"The prevalence of mitral regurgitation (MR), particularly degenerative MR (DMR), rises with advancing age. Elderly patients frequently carry increased surgical risk due to frailty and comorbidities, leading to a prohibitive risk of conventional surgery. For such patients, mitral transcatheter edge-to-edge repair (M-TEER) provides a minimally invasive alternative to surgical repair. Data from large registries, including TRAMI (Transcatheter Mitral Valve Interventions) and EXPAND (The MitraClip™ EXPAND Study of the Next Generation of MitraClip™ Devices), demonstrate high procedural success, low 30-day mortality (2-3%) and stroke rates (<1%), and durable improvements in functional status and quality of life (QoL) in elderly cohorts. Although definitions of \"elderly\" vary between studies (≥75, ≥80, or ≥85 years) and benefits are consistently observed, elderly was defined ≥75 years within this review. For selected patients unsuitable for M-TEER, transcatheter mitral valve replacement (TMVR) can achieve effective MR elimination, with reported 1-year mortality ranging from 7% to 17% in early transfemoral, transseptal experiences and up to 29% after transapical TMVR. This review summarizes current evidence on safety, functional outcomes, QoL, survival, emerging replacement strategies, and conservative management in elderly patients with MR.","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"911-916"},"PeriodicalIF":1.1,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13613887/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148759957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Alcohol consumption and cardiovascular health: balancing assumed benefits with the available evidence. 饮酒与心血管健康：平衡假定的益处与现有证据。

IF 1.1

Future cardiology Pub Date : 2026-09-01 Epub Date: 2026-09-16 DOI: 10.1080/14796678.2026.2732839

Miguel A Martínez-González, Juan Diego Sánchez-Vega

引用次数: 0

Can SGLT-2 inhibitors open a new door in cardio-oncology? The quest of the holy grail. SGLT-2抑制剂能打开心脏肿瘤学的新大门吗？寻找圣杯。

IF 1.1

Future cardiology Pub Date : 2026-09-01 Epub Date: 2026-09-15 DOI: 10.1080/14796678.2026.2732834

Athanasios Gatsis, Nikoleta Moutsou, Konstantinos Stavropoulos, Theocharis Koufakis, Dimitrios Patoulias

引用次数: 0

Watching 'AF'ter the Heart: the WATCHMAN^TM device for atrial fibrillation. 观看“心房颤动”：WATCHMANTM心房颤动设备。

IF 1.1

Future cardiology Pub Date : 2026-09-01 Epub Date: 2026-09-02 DOI: 10.1080/14796678.2026.2724777

Udit Choubey, Himanshi Banker, Griffin Perry, Gavin Schaefer-Hood, Kanishk Aggarwal, Vasishtha Avadhani Upadrasta, Ashwani Garg, Rohit Jain

{"title":"Watching 'AF'ter the Heart: the WATCHMANTM device for atrial fibrillation.","authors":"Udit Choubey, Himanshi Banker, Griffin Perry, Gavin Schaefer-Hood, Kanishk Aggarwal, Vasishtha Avadhani Upadrasta, Ashwani Garg, Rohit Jain","doi":"10.1080/14796678.2026.2724777","DOIUrl":"10.1080/14796678.2026.2724777","url":null,"abstract":"Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and a leading cause of cardioembolic stroke. In nonvalvular atrial fibrillation (NVAF), thrombus formation occurs predominantly within the left atrial appendage (LAA), making it a key therapeutic target. While oral anticoagulation remains standard for thromboembolic risk reduction, contraindications, elevated bleeding risk, and therapy intolerance drive the need for nonpharmacologic alternatives. This review examines the role of the WATCHMAN left atrial appendage occlusion (LAAO) device in NVAF-related stroke prevention, encompassing pathophysiologic rationale, device design, procedural technique, clinical evidence, post-implantation management, and outstanding evidence gaps. The PROTECT AF and PREVAIL trials established WATCHMAN-based LAAO as noninferior to warfarin for prevention of stroke, systemic embolism, and cardiovascular death, though early procedural complications underscored the importance of operator experience. Subsequent real-world registries confirmed safety and effectiveness in higher-risk, anticoagulation-ineligible populations. Newer-generation platforms including the WATCHMAN FLX and FLX Pro, demonstrate improved sealing performance and procedural safety, while contemporary randomized trials further define LAAO's role relative to DOAC therapy. WATCHMAN-based LAAO represents an important alternative for carefully selected patients, particularly those with high bleeding risk. Optimal patient selection, antithrombotic regimens, and long-term outcomes warrant continued investigation.","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"917-928"},"PeriodicalIF":1.1,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13613914/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148873637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clinical applicability of artificial intelligence electrocardiogram interpretation in Brugada syndrome: a diagnostic accuracy meta-analysis. 人工智能心电图解释在Brugada综合征中的临床适用性：诊断准确性荟萃分析。

IF 1.1

Future cardiology Pub Date : 2026-09-01 Epub Date: 2026-08-26 DOI: 10.1080/14796678.2026.2722829

Kevin Nathaniel Cuandra, Christopher Daniel Tristan, Indah Kurnia Hutabarat, Vina Sari Nugrahaning Widi, Dwi Nurcahya Ananda Suwarya, Raymond Elbert Budianto, Delinda Ivania Zhavira Wibowo, Siti Faiza Aliya, Ayu Mas Eka Pradnyani, Dhyani Paramita Wahyudi, Muhammad Atha Muafa, Irnizarifka Irnizarifka

{"title":"Clinical applicability of artificial intelligence electrocardiogram interpretation in Brugada syndrome: a diagnostic accuracy meta-analysis.","authors":"Kevin Nathaniel Cuandra, Christopher Daniel Tristan, Indah Kurnia Hutabarat, Vina Sari Nugrahaning Widi, Dwi Nurcahya Ananda Suwarya, Raymond Elbert Budianto, Delinda Ivania Zhavira Wibowo, Siti Faiza Aliya, Ayu Mas Eka Pradnyani, Dhyani Paramita Wahyudi, Muhammad Atha Muafa, Irnizarifka Irnizarifka","doi":"10.1080/14796678.2026.2722829","DOIUrl":"10.1080/14796678.2026.2722829","url":null,"abstract":"Introduction: Artificial intelligence electrocardiogram (AI-ECG) interpretation has emerged as a promising approach to identify Brugada syndrome (BrS). This review sought to investigate diagnostic viability and clinical applicability of AI-ECG interpretation models for detecting BrS.Methods: A systematic search (PubMed, Scopus, and ScienceDirect) was conducted in November 2025. STATA/BE (v17.0) was used to pool the overall metrics of the quantitative diagnostic test accuracy meta-analysis.Results: Seven studies comprising 15 AI-model analyses were included. AI-ECG interpretation yielded a pooled sensitivity of 0.82 [0.77-0.87], specificity of 0.81 [0.73-0.87], negative likelihood ratio of 0.22 [0.16-0.29], positive likelihood ratio of 4.31 [2.94-6.33], and area under the curve of 0.88 [0.85-0.91]. Clinical applicability assessed using Fagan's nomogram showed minimal diagnostic value for general population screening (pretest probability 0.05%). However, in case-finding (5%) and high-risk scenarios (20%), positive results substantially increased posttest probability (to 18% and 52%, respectively), while negative results reduced it to 1% and 5%. Overall, the Fagan plot indicated a beneficial trend toward rule-in utility rather than rule-out utility.Conclusion: AI-ECG interpretation demonstrated a good overall diagnostic performance for detecting BrS and may serve as valuable decision-support assisting clinicians in clinically suspected or high-risk populations.Protocol registration: www.crd.york.ac.uk/prospero identifier is CRD420261298566.","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"945-955"},"PeriodicalIF":1.1,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13613878/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148818209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Emotion-triggered spontaneous coronary artery dissection in a patient with multiple cardiovascular risk factors: navigating the diagnostic overlap with atherosclerotic acute coronary syndrome and Takotsubo cardiomyopathy. 多重心血管危险因素患者的情绪引发的自发性冠状动脉夹层：导航与动脉粥样硬化性急性冠状动脉综合征和Takotsubo心肌病的诊断重叠

IF 1.1

Future cardiology Pub Date : 2026-09-01 Epub Date: 2026-08-27 DOI: 10.1080/14796678.2026.2722562

Richmond Buckner, Adama Seidu, Abraham Carboo, Amanuel Genebo, Beamlak Adamu, Stephen Djanie, Angelina Molkina

{"title":"Emotion-triggered spontaneous coronary artery dissection in a patient with multiple cardiovascular risk factors: navigating the diagnostic overlap with atherosclerotic acute coronary syndrome and Takotsubo cardiomyopathy.","authors":"Richmond Buckner, Adama Seidu, Abraham Carboo, Amanuel Genebo, Beamlak Adamu, Stephen Djanie, Angelina Molkina","doi":"10.1080/14796678.2026.2722562","DOIUrl":"10.1080/14796678.2026.2722562","url":null,"abstract":"Spontaneous coronary artery dissection (SCAD), once considered rare, is increasingly recognized as a cause of acute coronary syndrome (ACS) owing to advances in coronary imaging. Although classically described in women with no or minimal cardiovascular risk factors, differentiation from atherosclerotic myocardial infarction remains challenging when multiple risk factors are present. Accurate diagnosis by coronary angiography is essential, because interventions such as percutaneous coronary intervention and thrombolysis may cause harm in SCAD. Diagnostic overlap with Takotsubo cardiomyopathy (TTC; also called stress cardiomyopathy) further complicates early evaluation. Important gaps remain regarding who is at risk, the triggers involved, and the association with fibromuscular dysplasia (FMD). We report a 51-year-old woman with multiple cardiovascular risk factors who developed SCAD two days after an acute emotional stressor, with negative FMD screening.","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"939-944"},"PeriodicalIF":1.1,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13613879/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148827294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Thrombophilias associated with patent foramen ovale (PFO) in patients after an episode of cryptogenic stroke. 隐源性卒中发作后患者与卵圆孔未闭（PFO）相关的血栓形成。

IF 1.1

Future cardiology Pub Date : 2026-08-01 Epub Date: 2026-08-12 DOI: 10.1080/14796678.2026.2713328

Michał Tworek, Katarzyna Trojanowicz, Zuzanna Sachajko, Klaudia Bielecka, Sylwia Szczepara, Miłosz Tworek, Maria Olszowska, Grzegorz Kopeć, Monika Komar

{"title":"Thrombophilias associated with patent foramen ovale (PFO) in patients after an episode of cryptogenic stroke.","authors":"Michał Tworek, Katarzyna Trojanowicz, Zuzanna Sachajko, Klaudia Bielecka, Sylwia Szczepara, Miłosz Tworek, Maria Olszowska, Grzegorz Kopeć, Monika Komar","doi":"10.1080/14796678.2026.2713328","DOIUrl":"10.1080/14796678.2026.2713328","url":null,"abstract":"Patent foramen ovale (PFO) is a recognized risk factor for cerebral ischemia. Hypercoagulable states are additional cofactors that may increase the risk of ischemic stroke. In this review, we aimed to summarize current knowledge on coagulation disorders and analyze how the coexistence of PFO and thrombophilia influences the risk of cerebral ischemia. We conducted a literature search of the PubMed database to identify studies examining the coexistence of PFO and thrombophilia, as well as their impact on the risk of cerebral ischemia. We found that selected hypercoagulable states, especially the prothrombin G20210A mutation and, to a lesser extent, antiphospholipid antibodies and factor V Leiden mutation are associated with a higher risk of cerebral ischemia in PFO patients. Moreover, we investigated the role of percutaneous PFO closure in patients with hypercoagulability. Percutaneous PFO closure is a safe and effective therapeutic strategy for secondary prevention of cerebral ischemia. Furthermore, some studies suggest that it may also be explored in the context of primary prevention in selected patients with hypercoagulability; however, this approach is not currently supported by clinical guidelines. Further studies are needed to clarify the role of thrombophilia in the management of patients with PFO-related stroke.","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"875-884"},"PeriodicalIF":1.1,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13540165/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148712055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Association between the NAPLES score and malignant ventricular arrhythmias in cardiomyopathy patients. 那不勒斯评分与心肌病患者恶性室性心律失常的关系。

IF 1.1

Future cardiology Pub Date : 2026-08-01 Epub Date: 2026-07-17 DOI: 10.1080/14796678.2026.2704395

Kübra Okumuş, Özge Çakmak Karaaslan

{"title":"Association between the NAPLES score and malignant ventricular arrhythmias in cardiomyopathy patients.","authors":"Kübra Okumuş, Özge Çakmak Karaaslan","doi":"10.1080/14796678.2026.2704395","DOIUrl":"10.1080/14796678.2026.2704395","url":null,"abstract":"Background: Malignant ventricular arrhythmias are a major cause of sudden cardiac death in patients with cardiomyopathy. Traditional risk markers, including left ventricular ejection fraction, have limited ability to identify high-risk individuals.Objective: To investigate the association between the Naples Prognostic Score (NAPLES), a marker of inflammatory and nutritional status, and malignant ventricular arrhythmias in patients with cardiomyopathy and cardiac implantable electronic devices (CIEDs).Methods: This retrospective study included 299 patients with cardiomyopathy and CIEDs. The NAPLES score was calculated using serum albumin, total cholesterol, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio. Patients were classified into low (0-1) and high (2-4) NAPLES groups. Independent predictors were evaluated using multivariable logistic regression analysis.Results: Malignant ventricular arrhythmias were more common in patients with high NAPLES scores than in those with low scores (46.3% vs. 36.1%, p = 0.042). High NAPLES score was independently associated with malignant ventricular arrhythmias (OR: 2.00, 95% CI: 1.14-3.23, p = 0.027). Each one-point increase in NAPLES score was also associated with increased arrhythmic risk (OR: 1.40, 95% CI: 1.08-1.81, p = 0.018).Conclusion: The NAPLES score is independently associated with malignant ventricular arrhythmias and may aid arrhythmic risk stratification in patients with cardiomyopathy and CIEDs.","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"803-810"},"PeriodicalIF":1.1,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13540186/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148470043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0